Icariin attenuates the enhanced prothrombotic state in atherosclerotic rabbits independently of its lipid-lowering effects

Planta Medica

Volumn 79, Issue 9, 2013, Pages 731-736

  Zhang, Wei Ping ^a   Bai, Xiao Jun ^a   Zheng, Xiao Pu ^a   Xie, Xiao Lu ^a   Yuan, Zu Yi ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

atherosclerosis; Berberidaceae; Epimedium brevicornum; icariin; lipid lowering effect; prothrombotic state

Indexed keywords

CHOLESTEROL; ICARIIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRAVASTATIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD RHEOLOGY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; EXPERIMENTAL RABBIT; HOMEOSTASIS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MALE; NONHUMAN; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA, ABDOMINAL; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, LDL; DRUGS, CHINESE HERBAL; FIBRINOLYTIC AGENTS; FLAVONOIDS; HYPERLIPIDEMIAS; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET ACTIVATION; PLATELET ADHESIVENESS; RABBITS; TISSUE PLASMINOGEN ACTIVATOR;

BERBERIDACEAE; EPIMEDIUM BREVICORNUM; ORYCTOLAGUS CUNICULUS;

EID: 84879222637     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1328551     Document Type: Article

References (37)

1. Iwamoto T., Jingzi J., Sugiyama T., Umahara T., Takasaki M. Prognosis of the elderly with asymptomatic atherosclerotic plaques of the carotid arteries. Intern Med: 2002; 41 526 531
2. Slager C. J., Wentzel J. J., Gijsen F. J., Thury A., van der Wal A. C., Schaar J. A., Serruys P. W. The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications. Nat Clin Pract Cardiovasc Med: 2005; 2 456 464
3. Jiang Y., Kohara K., Hiwada K. Association between risk factors for atherosclerosis and mechanical forces in carotid artery. Stroke: 2002; 31 2319 2324
4. Velcheva I., Antonova N., Titianova E., Damianov P., Dimitrov N., Ivanov I. Hemorheological parameters in correlation with the risk factors for carotid atherosclerosis. Clin Hemorheol Microcirc: 2006; 35 195 198
5. Massberg S., Brand K., Grüner S., Page S., Müller E., Müller I., Bergmeier W., Richter T., Lorenz M., Konrad I., Nieswandt B., Gawaz M. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med: 2002; 196 887 896
6. Weber C. Platelets and chemokines in atherosclerosis: partners in crime. Circ Res: 2005; 96 612 616
7. Reininger A. J., Bernlochner I., Penz S. M., Ravanat C., Smethurst P., Farndale R. W., Gachet C., Brandl R., Siess W. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. J Am Coll Cardiol: 2010; 55 1147 1158
8. Lupu F., Bergonzelli G. E., Heim D. A., Cousin E., Genton C. Y., Bachmann F., Kruithof E. K. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb: 1993; 13 1090 1100
9. Eitzman D. T., Westrick R. J., Xu Z., Tyson J., Ginsburg D. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery. Blood: 2000; 96 4212 4215
10. Notarbartolo A., Davì G., Averna M., Barbagallo C. M., Ganci A., Giammarresi C., La Placa F. P., Patrono C. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type II a hypereholesterolemia. Arterioscler Thromb Vasc Biol: 1995; 15 247 251
11. Shimomura I., Funahashi T., Takahashi M., Maeda K., Kotani K., Nakamura T., Yamashita S., Miura M., Fukuda Y., Takemura K., Tokunaga K., Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med: 1996; 2 800 803
12. Wu J., Du J., Xu C., Le J., Xu Y., Liu B., Dong J. Icariin attenuates social defeat-induced down-regulation of glucocorticoid receptor in mice. Pharmacol Biochem Behav: 2011; 98 273 278
13. Song Y. H., Cai H., Gu N., Qian C. F., Cao S. P., Zhao Z. M. Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure. J Pharm Pharmacol: 2011; 63 541 549
14. Xu C. Q., Liu B. J., Wu J. F., Xu Y. C., Duan X. H., Cao Y. X., Dong J. C. Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF- κ B signaling pathway. Eur J Pharmacol: 2010; 642 146 153
15. Koizumi H., Yu J., Hashimoto R., Ouchi Y., Okabe T. Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells. FEBS Lett: 2010; 584 2440 2444
16. Zhang Z. B., Yang Q. T. The testosterone mimetic properties of icariin. Asian J Androl: 2006; 8 601 605
17. Nathan L., Shi W., Dinh H., Mukherjee T. K., Wang X., Lusis A. J., Chaudhuri G. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci USA: 2001; 98 3589 3593
18. Liu L. Y., Wen J. F., Tu J. H., Zhong Z. L., Wu J. X. The effects of HOE 642 against atherosclerosis induced by high lipid diet in rabbits. Chin J Arterioscler: 2002; 10 1 5
19. Lolekha P. H., Srisawasdi P., Jearanaikoon P., Wetprasit N., Sriwanthana B., Kroll M. H. Performance of four sources of cholesterol oxidase for serum cholesterol determination by the enzymatic endpoint method. Clin Chim Acta: 2004; 339 135 145
20. Sikka M., Tandon R., Rusia U., Madan N. Validation of ESR analyzer using Westergren ESR method. Indian J Pathol Microbiol: 2007; 50 634 635
21. Pinthong D., Songsermsakul P., Rattanachamnong P., Kendall D. A. The effects of imidazoline agents on the aggregation of human platelets. J Pharm Pharmacol: 2004; 56 213 220
22. Chandler B. W., Trimble S. L., Loo S. C., Mornin D. Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma. Blood: 1990; 5 930 937
23. Johnstone M. T., Perez A. S., Nasser I., Stewart R., Vaidya A., Al Ammary F., Schmidt B., Horowitz G., Dolgoff J., Hamilton J., Quist W. C. Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model. Circulation: 2004; 110 2060 2065
24. Alessi M. C., Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol: 2006; 26 2200 2207
25. Farndale R. W., Sixma J. J., Barnes M. J., de Groot P. G. The role of collagen in thrombosis and hemostasis. J Thromb Haemost: 2004; 2 561 573
26. Andrews H. E., Aitken J. W., Hassall D. G., Skinner V. O., Bruckdorfer K. R. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. Biochem J: 1987; 242 559 564
27. Spieker L. E., Ruschitzka F., Badimon J. J., Noll G., Corti R. Shear stress-dependent platelet function after LDL cholesterol apheresis. Thromb Res: 2004; 113 395 398
28. Hanke H., Hanke S., Bruck B., Brehme U., Gugel N., Finking G., Mück A. O., Schmahl F. W., Hombach V., Haasis R. Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. Atherosclerosis: 1996; 121 129 138
29. Langer C., Gansz B., Goepfert C., Engel T., Uehara Y., von Dehn G., Jansen H., Assmann G., von Eckardstein A. Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages. Biochem Biophys Res Commun: 2002; 296 1051 1057
30. Hwang S. Y., Son D. J., Kim I. W., Kim D. M., Sohn S. H., Lee J. J., Kim S. K. Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits. Phytother Res: 2008; 22 778 783
31. Kensey K. R., Cho Y. I., Chang M. Effects of whole blood viscosity on atherogenesis. J Invasive Cardiol: 1997; 9 17 24
32. Holme P. A., Orvim U., Hamers M. J., Solum N. O., Brosstad F. R., Barstad R. M., Sakariassen K. S. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol: 1997; 17 646 653
33. De Taeye B., Smith L. H., Vaughan D. E. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. Curr Opin Pharmacol: 2005; 5 149 154
34. Johnstone M. T., Perez A. S., Nasser I., Stewart R., Vaidya A., Al Ammary F., Schmidt B., Horowitz G., Dolgoff J., Hamilton J., Quist W. C. Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model. Circulation: 2004; 110 2060 2065
35. Kario K., Matsuo T., Hoshide S., Kobayashi H., Sakata T., Mizuno O., Mitsuhashi T., Ikeda U., Miyata T., Shimada K. Lipid-lowering therapy corrects endothelial cell dysfunction in a short time but does not affect hypercoagulable state even after long-term use in hyperlipidemic patients. Blood Coagul Fibrinolysis: 1999; 10 269 276
36. Goglia L., Tosi V., Sanchez A. M., Flamini M. I., Fu X. D., Zullino S., Genazzani A. R., Simoncini T. Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo. Mol Hum Reprod: 2010; 16 761 769
37. Campelo A. E., Cutini P. H., Massheimer V. L. Testosterone modulates platelet aggregation and endothelial cell growth through nitric oxide pathway. J Endocrinol: 2012; 213 77 87